RUBY GREER: Open Payments
NPI 1396222592 · HELENA, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$137 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $43 · 2025 $137
Food & beverage: $137
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $36 |
| Incyte Corporation | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
| Janssen Biotech, Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $19 |
| Organon LLC | 1 | $18 |
Products named: OTEZLA, OPZELURA, TALTZ, TREMFYA, Xolair, VTAMA.
Industry payments across MT — which companies pay providers there.
